HTGC Hercules Capital, Inc. Insider Trading

Director Theodosopoulos buys 7,317 shares of HTGC at $14.35; cluster of 6 other insiders buying within 14 days at depressed 52-week position

Director Nikos Theodosopoulos purchased 7,317 shares at $14.35 on 2026-03-26, increasing his holdings from 22,045 to 29,362 shares (+33.2%). This transaction occurs within a broader insider buying cluster: 6 other insiders also purchased within the past 14 days, suggesting coordinated or parallel conviction at current price levels. The stock is trading at $14.20, down 27.5% from its 52-week high of $19.59, positioning this near the lower end of the annual range. Theodosopoulos's same-ticker history shows mixed recent signals: his February 2026 buys have posted negative 30-day returns (-2.2%, -9.5%), while his prior 2025 and 2024 buys at HTGC demonstrated positive 90-day outcomes. The stock's 90-day decline of 24.4% and the director's persistent accumulation despite recent downside may indicate divergent confidence, though his longer-term same-ticker buying record includes instances of well-timed entries at the 90-day horizon.

Director Loo Wade purchased 7,317 shares of HTGC at $14.35 on 2026-03-26 for $104,998.95; cluster buy pattern with 6 other insiders in past 14 days

Director Loo Wade's acquisition of 7,317 shares represents a substantial 108.7% increase to his holdings at HTGC, with a concurrent cluster pattern showing 6 other insiders buying within the past 14 days. His same-ticker history at HTGC shows 2 of 2 prior measurable buys were well-timed at the 90-day mark (returns of +11.6% and +3.2%), indicating a historical pattern of buying before subsequent stock appreciation at this ticker. The stock currently trades 27.5% below its 52-week high of $19.59, while the company carries a low P/E of 6.73 on net income of $119,685,000.00 and a market cap of $2,608,475,205.40. The coordinated multi-insider buy activity alongside the director's substantial position increase and his prior track record of well-timed purchases at this ticker warrant investor attention.

Director Aguirre DeAnne purchased 7,317 shares of HTGC at $14.35, boosting holdings 213.2%; 6 other insiders bought within 14 days.

Director Aguirre DeAnne acquired 7,317 shares at $14.35 on 2026-03-26, increasing her HTGC position from 3,432 to 10,749 shares (+213.2% net change). This purchase occurs amid a cluster of 6 other insider buys within the past 14 days, suggesting coordinated capital deployment at the company level. Her prior two purchases at HTGC (2025-05-08 and 2024-08-06) both produced positive 90-day returns of 11.6% and 3.4% respectively, indicating a historical pattern of well-timed accumulation at this ticker. The stock is currently trading at $14.20, down 24.4% over 90 days and -27.5% from its 52-week high of $19.59, but the company's fundamentals show a P/E of 6.73 and net income of $119,685,000.00 on a $2.6B market cap. The cluster buy pattern combined with this insider's consistent track record at the same ticker merits investor attention.

Director Gayle A Crowell buys 7,317 shares of HTGC at $14.35; cluster of 6 other insiders also bought within 14 days amid 24.4% 90-day decline

Crowell purchased 7,317 shares at $14.35, increasing holdings by 8.1% to 97.6K shares. The broader context reveals a coordinated signal: 6 other insiders also purchased within the past 14 days, forming a cluster buy pattern at a point when HTGC has declined 24.4% over 90 days and is -27.5% from its 52-week high of $19.59. At the same ticker, Crowell's prior 4 measured buys showed a 75% timing success rate, with 3 of 4 trades followed by 90-day gains (ranging from +4.2% to +11.6%), though his most recent February 2026 buy at HTGC returned -6.7% at the 30-day mark. The company's fundamentals are solid (P/E 6.73, $119.7M net income, $2.6B market cap), and the cluster buying suggests management sees value at depressed levels. Investors should monitor whether this coordinated accumulation by multiple insiders validates or contradicts the stock's recent downtrend.

Director Randhawa buys 2,926 shares of HTGC at $14.35; 6 insiders bought within 14 days

Randhawa Paramjeet K, a Director, purchased 2,926 shares at $14.35 on 2026-03-26, increasing holdings by 15.0% to 22,486 shares. This transaction is noteworthy because it occurs as part of a cluster pattern: 6 other insiders also bought within the past 14 days, suggesting coordinated or independently synchronized confidence. The stock currently trades at $14.20, down 27.5% from its 52-week high of $19.59, presenting a historically depressed entry point relative to recent trading ranges. Randhawa's prior trade at HTGC in August 2024 was well-timed, delivering +5.8% over 90 days, and his cross-ticker track record shows 100% win rate on 2 prior buys with an average 90-day return of +5.8%, though current valuation stress (down 24.4% over 90 days) means execution timing remains uncertain.

Director Fallon Thomas J bought 7,300 shares of HTGC at $14.30 amid cluster buy; stock down 27.5% from 52-week high.

Director Fallon Thomas J purchased 7,300 shares at $14.30 on 2026-03-26, increasing his holdings by +4.9% to 157,669 shares total. This transaction is part of a cluster pattern: 6 other insiders bought within the past 14 days, suggesting coordinated or simultaneous confidence at current levels. The timing context is mixed—while his cross-ticker track record shows a 100.00% 90-day win rate across 5 prior buys, his prior purchases at HTGC have underperformed in the recent window (three consecutive buys on 2026-02-27, 2026-02-24, and 2026-02-17 showed 30-day returns of -2.2%, -6.1%, and -9.2% respectively). The stock is currently trading 27.5% below its 52-week high of $19.59, and the company carries a P/E of 6.73 with net income of $119,685,000.00, suggesting potential value at depressed levels. Investors should monitor whether this cluster buy precedes a reversal or whether the recent downtrend at HTGC continues despite insider accumulation.

Director Badavas buys 3,658 shares of HTGC at $14.35; holdings rise to 5,070 shares (+259.1%). Stock down 27.5% from 52-week high, cluster of 6 other insiders buying in past 14 days.

Director Robert P Badavas purchased 3,658 shares at $14.35 on 2026-03-26, tripling his HTGC position from 1,412 to 5,070 shares and committing $52,492.30 to the stock. The purchase occurs after a 24.4% decline over the past 90 days and at a price 27.5% below the 52-week high of $19.59, suggesting opportunistic accumulation during a period of weakness. Notably, 6 other insiders have also purchased within the past 14 days, forming a cluster buy pattern that indicates coordinated confidence in the valuation at current levels. His prior HTGC trade on 2025-05-08 delivered a +11.6% return at the 90-day mark, providing a single data point of successful timing at this ticker, though the two more recent February purchases at HTGC remain outcome-negative in the 30-day window.

COO Christian Follmann purchases 5,000 shares of HTGC at $14.68; 9 other insiders also bought within past 14 days.

Follmann, the Chief Operating Officer, purchased 5,000 shares at $14.68 on 2026-03-04 for $73,400.00, expanding his holdings from 145.1K to 150.1K shares. This is part of a broader cluster: 9 other insiders also bought within the past 14 days, suggesting coordinated conviction among leadership. His cross-ticker track record shows 2 prior buys with an average 90-day return of +12.9% and a 100.00% win rate, indicating consistent success with buy decisions. However, the company's stock is down 27.7% from its 52-week high of $20.91 and has declined 13.7% over 30 days and 20.4% over 90 days, raising the question of whether this purchase reflects a contrarian position or addresses market weakness. The company's fundamentals remain solid: net income of $119.7M, a P/E of 7.16, and a market cap of $2.8B, supporting the notion that the insider group may view current valuations as attractive.

Director Randhawa bought 3,050 shares of HTGC at $14.78; 9 other insiders bought within 14 days amid -27.7% YTD decline.

Randhawa Paramjeet K, a Director, purchased 3,050 shares at $14.78 on 2026-03-04, increasing his holdings by 18.5% to 19,560 shares and investing $45,079.00. The stock is currently priced at $15.11, down -27.7% from its 52-week high of $20.91 and down -20.4% over the past 90 days. Notably, this buy was preceded by a cluster: 9 other insiders also bought within the past 14 days, indicating coordinated conviction across the insider group. Randhawa's prior buy at this ticker on 2024-08-06 returned +5.8% over 90 days, consistent with his cross-ticker track record of 100% win rate on buys with a 90-day average return of +5.8%. The company trades at a P/E of 7.16 with a $2.8B market cap and net income of $119.7M, suggesting it is trading at a material discount to historical valuation. The cluster-buy pattern combined with the significant price weakness and insider's historical success at timing buys warrants investor attention to whether this represents a floor-building opportunity or broader validation of intrinsic value at depressed levels.

Director Theodosopoulos buys 2,600 shares of HTGC at $14.21; stock down 33.6% from 52-week high, 7 insiders bought in past 14 days

Theodosopoulos Nikos, a Director at Hercules Capital, purchased 2,600 shares at $14.21 on 2026-02-27 for $36,946.00, increasing his holdings by 13.7% to 21,523 shares. The timing coincides with a significant price decline: HTGC is trading -33.6% from its 52-week high of $21.41 and down -23.3% over the past 30 days. More notably, this buy is part of a cluster pattern—7 other insiders purchased shares within the past 14 days, suggesting coordinated confidence. Theodosopoulos's prior two buys at HTGC resulted in 90-day returns of +11.6% and +6.1%, establishing a pattern of well-timed purchases at this ticker. The company's fundamentals remain solid with a P/E of 6.73 and $119.7M in net income, indicating the stock may be trading at a discount relative to earnings power.